Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

PABPC2 Activators

Common PABPC2 Activators include, but are not limited to Actinomycin D CAS 50-76-0, Mithramycin A CAS 18378-89-7, Leptomycin B CAS 87081-35-4, 5-Azacytidine CAS 320-67-2 and DRB CAS 53-85-0.

PABPC2, standing for Poly(A) Binding Protein Cytoplasmic 2, belongs to the family of poly(A) binding proteins that are renowned for their pivotal roles in the polyadenylation and subsequent translation of eukaryotic mRNAs. These proteins, inclusive of PABPC2, exhibit a strong affinity to the poly(A) tail found on mRNA molecules, a feature that is instrumental in conferring stability to the mRNA, thereby preventing its premature degradation. Furthermore, the binding of PABPC2 and its counterparts to the poly(A) tail is instrumental in ensuring that the mRNA is efficiently exported from the nucleus and aptly positioned on the ribosome for translation. Given the centrality of mRNA in cellular protein synthesis processes, PABPC2's role in safeguarding mRNA stability and facilitating its translation is of paramount importance for the seamless operation of cellular machinery.

PABPC2 Activators are molecules engineered to enhance or potentiate the activity of PABPC2. By amplifying the functionality of PABPC2, such activators could bolster the stabilization of mRNAs and, in turn, fine-tune the subsequent translation processes. This would mean that, in the presence of these activators, there might be a marked increase in protein synthesis rates, given the enhanced stability and readiness of mRNAs for translation. When contemplating the design or discovery of PABPC2 activators, a deep understanding of the protein's molecular architecture, its interaction dynamics with mRNAs, and its collaborative role in the translation initiation complex would be indispensable. The intriguing prospect here lies in the ability of such activators to increase protein synthesis rates, opening avenues for insights into cellular dynamics and offering a microscopic lens to view and influence the molecular ballet within cells.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interferes with DNA-dependent RNA synthesis, potentially affecting the transcription and stability of various mRNAs, including PABPC2.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

By binding to DNA and inhibiting transcription, it can alter the expression of several genes, possibly impacting PABPC2.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Known to inhibit nuclear export, which might influence the cytoplasmic levels of nuclear proteins and mRNAs, including PABPC2.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor that can influence gene expression patterns, possibly affecting PABPC2 expression.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits RNA polymerase II, potentially affecting transcription of genes, including PABPC2.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

A potent inhibitor of RNA polymerase II, potentially reducing the transcription of various genes, including PABPC2.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor that can influence gene expression by modifying chromatin structure, potentially affecting PABPC2 levels.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

By inhibiting glycolysis, it can impact various cellular processes, potentially influencing PABPC2 expression.

Oxaliplatin

61825-94-3sc-202270
sc-202270A
5 mg
25 mg
$112.00
$394.00
8
(1)

A chemotherapy drug that causes DNA damage, potentially influencing the transcription and stability of several mRNAs, including PABPC2.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Inhibits DNA topoisomerase I, which can impact transcription and replication, potentially affecting PABPC2 expression.